Elisabetta Leo
Molecular Biology · 2010
A researcher in the Science corpus: 1 paper; trusts 3 researchers and is trusted by 2 researchers here, as inferred from the citation graph.
Subfields
- Molecular Biology — 6 citations into it; #14,365 of 17,773 by trust here, #14,176 by citations
- Oncology — 5 citations into it; #1,245 of 1,698 by trust here, #1,421 by citations
Whom Elisabetta Leo trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
Who trusts Elisabetta Leo overall
Papers from Elisabetta Leo's perspective
Ordered by how strongly the researchers Elisabetta Leo trusts endorse each paper. Same corpus, a different order for every researcher.
- Topoisomerase I inhibitors: camptothecins and beyond (Nature Reviews. Cancer)
- Cell cycle kinases as therapeutic targets for cancer (Nature reviews. Drug discovery)
- Inactivation of the apoptosis effector Apaf-1 in malignant melanoma (Nature)
- The Bloom's syndrome helicase suppresses crossing over during homologous recombination (Nature)
- The role of PML in tumor suppression. (Cell)
- A senescence program controlled by p53 and p16INK4a contributes to the outcome of cancer therapy. (Cell)
- The microcosmos of cancer (Nature)
- 53BP1 inhibits homologous recombination in Brca1-deficient cells by blocking resection of DNA breaks (Cell)
- The DNA damage response and cancer therapy (Nature)
- The diverse biological roles of mammalian PARPS, a small but powerful family of poly-ADP-ribose polymerases. (Frontiers in Bioscience)
Their papers
- DNA Topoisomerases and Their Poisoning by Anticancer and Antibacterial Drugs (2010) — 1,790 citations